新型肥胖指标与糖尿病视网膜病变的关系研究进展

朱 晓婷1, 姚 明言2, 展倩 丽*3
1、承德医学院研究生学院;保定市第一中心医院全科医疗科
2、保定市第一中心医院内分泌科
3、保定市第一中心医院全科医疗科

摘要


糖尿病视网膜病变（DR）是糖尿病最常见的微血管并发症之一，严重威胁患者视力健康。近年来，随着糖尿病患者不断增加，糖尿病视网膜病变的患病率也在逐年上升，然而在病理生理研究中发现，随着肥胖率的不断攀升，肥胖与DR的关系日益受到关注。传统体重指数（BMI）在评估肥胖与DR关系时存在局限性，近年来，新型肥胖指标如内脏脂肪指数（VAI）、脂质蓄积指数（LAP）、腰围身高比（WHtR）、身体形态指数（ABSI）等逐渐应用于临床研究。本文就新型肥胖指标与糖尿病视网膜病变的相关性进行综述，探讨其临床应用研究价值，为糖尿病视网膜病变的早期筛查和干预提供新的方法。

关键词


糖尿病视网膜病变；肥胖症；内脏脂肪指数、腰围身高比；身体形态指数；脂质蓄积指数

全文:

PDF


参考


[1]Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.[J].Lancet (London, England),2023,402(10397):203-234.

[2]中华医学会糖尿病学分会视网膜病变学组.糖尿病视网膜病变防治专家共识.中华糖尿病杂志，2018，10（04）：241-247.

[3]Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715-725.

[4]Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85(1009):1-10.

[5]Chen J, Li YT, Niu Z, et al. Association of Visceral Obesity Indices With Incident Diabetic Retinopathy in Patients With Diabetes: Prospective Cohort Study. JMIR Public Health Surveill. 2024;10:e48120.

[6]Ko SH, Jung Y. Energy Metabolism Changes and Dysregulated Lipid Metabolism in Postmenopausal Women. Nutrients. 2021;13(12):4556.

[7]Gao B, Liu Y, Ding C, Liu S, Chen X, Bian X. Comparison of visceral fat area measured by CT and bioelectrical impedance analysis in Chinese patients with gastric cancer: a cross-sectional study. BMJ Open. 2020;10(7):e036335

[8]Knapp M, Tu X, Wu R. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Acta Pharmacol Sin. 2019;40(1):1-8.

[9]Goossens GH. The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function. Obes Facts. 2017;10(3):207-215.

[10]Wang Y, Miao Y, Wan Q. Association Between Triglyceride-Glucose Index and Waist-To-Hip Ratio with Type 2 Diabetic Retinopathy in the Chinese Population: A Cross-Sectional Study. Endocr Res. 2024;49(4):203-212.

[11]Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556-564.

[12]Song SJ, Wong TY. Current concepts in diabetic retinopathy. Diabetes Metab J. 2014;38(6):416-425.

[13]Upadhyay R, Crystal R, Ding H .Role of SLMAP Genetic Variants in Susceptibility of Diabetes and Diabetic Retinopathy in Qatari Population[J].The FASEB Journal,2015,29

[14]Amato MC, Giordano C, Galia M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920-922.

[15]Lin, S., Gupta, B., James, N., & Ling, R. H. (2017). Visual impairment certification due to diabetic retinopathy in North and Eastern Devon. Acta ophthalmologica, 95(8), e756-e762.

[16]Moh A, Neelam K, Zhang X, et al. Excess visceral adiposity is associated with diabetic retinopathy in a multiethnic Asian cohort with longstanding type 2 diabetes. Endocr Res. 2018;43(3):186-194.

[17]Corrêa, Márcia Mara et al. “Performance of the waist-to-height ratio in identifying obesity and predicting non-communicable diseases in the elderly population: A systematic literature review.” Archives of gerontology and geriatrics vol. 65 (2016): 174-82.

[18]张明华，李静，王磊.新型肥胖指标与糖尿病微血管并发症关系的研究进展.中华糖尿病杂志，2022，14（3）：245-250.

[19]Wang Y, et al. Association of novel adiposity indices with diabetic retinopathy in Chinese adults: A cross-sectional study. Diabetes Res Clin Pract, 2021, 178: 108940.

[20]陈思远，刘芳，赵明明.脂质蓄积指数与2型糖尿病视网膜病变的相关性研究.中国实用内科杂志，2023，43（2）：156-160.

[21]Kim HK, et al. A Body Shape Index Has a Good Correlation with Postprandial Hyperglycemia and Risk of Diabetic Retinopathy in Korean Patients with Type 2 Diabetes. Endocrinol Metab, 2022, 37(1): 145-154.

[22]周晓红，等.内脏脂肪指数对糖尿病视网膜病变的预测价值.中华内分泌代谢杂志，2021，37（8）：703-708.

[23]Wang H, Qin Y, Niu J, et al. Evolving perspectives on evaluating obesity: from traditional methods to cutting-edge techniques. Ann Med. 2025;57(1):2472856. doi:10.1080/07853890.2025.2472856


Refbacks

  • 当前没有refback。